These developments have not only deepened our understanding of STING biology and regulation but have also created a robust pipeline of therapeutic candidates with potential applications across a spectrum of diseases, from autoimmune disorders to cancer immunotherapy. The gene discussed is STING1; the disease is autoimmune disease.